WuXi Biologics Signs On As Premier Sponsor of the 2016 BioProcess International Awards

BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces an agreement with WuXi Biologics to become a premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the People, Organizations and Technology Applications in Bioprocessing.

The BPI Awards has been developed to encourage the leaders, scientists, manufacturers, and suppliers to raise the awareness of their individual achievements, collaborations, successful business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base.

“The 2016 BPI Award program honors the innovative companies and individuals that are driving the biopharmaceutical industry forward,” said Brian Caine, BioProcess International’s Co-Founder and Publisher. “WuXi Biologics has reinforced their position as a leader in the contract services marketplace, and continues to reinvest in their capabilities, providing the biopharmaceutical market with an expanded service portfolio. We welcome them as a premier sponsor of the 2016 BioProcess International Awards.”

“In order to provide more effective and affordable medicines to our global community, it is imperative as an industry we continue to find novel means to enhance the efficiency, safety and economics of bioprocessing,” said Chris Chen, PhD, Chief Executive Officer of WuXi Biologics (a wholly-owned subsidiary of WuXi AppTec). “WuXi Biologics is proud to sponsor those individuals and companies that bring new insights and mechanisms to improve all aspects of biologics manufacturing.”

The nominations deadline is June 30, 2016. To submit your nomination visit: https://bioprocessintl.com/awards.

Awards will be granted recognizing achievements within the following categories:

The People:

The Organizations:

The Technologies: